Document is current
Any future updates will be listed below
-
Authors
Maksoud, Semer https://orcid.org/0000-0001-9773-9415
Schweiger, Markus W. https://orcid.org/0000-0002-8197-3044
Tabet, Elie I. https://orcid.org/0000-0002-6905-1047
Xiao, Tianhe
Hokayem, Joelle El
Zinter, Max
Carvalho, Litia A.
Breyne, Koen
Noske, David P.
Chiocca, Ennio Antonio
Tannous, Bakhos A. https://orcid.org/0000-0001-7062-0684
- License Information
-
More Information
Article History
Received: 4 January 2024
Accepted: 28 July 2024
First Online: 14 August 2024
Declarations
:
: This research study has been approved by the Institutional Animal Care and Use Committee (IACUC) at Massachusetts General Hospital.
: Not applicable.
: Not applicable.
: E.A. Chiocca holds ownership interest (including patents) in DNAtrix and is a consultant/advisory board member for Advantagene, DNAtrix, and NanoTherapeutics. No potential conflicts of interest were disclosed by the other authors.
